Supplemental Figure 1 from Early Changes in Circulating Cell-Free KRAS G12C Predict Response to Adagrasib in KRAS Mutant Non–Small Cell Lung Cancer Patients
Cloud P. Paweletz, Grace A. Heavey, Yanan Kuang, Emily Durlacher et autres
0 citations
Thian Kheoh
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
217Publications signalées
21901Citations signalées
0Affiliations récentes
Les domaines associés
Prostate Cancer Treatment and ResearchRadiopharmaceutical Chemistry and ApplicationsLung Cancer Treatments and MutationsProstate Cancer Diagnosis and TreatmentCancer Genomics and Diagnostics
Les publications récentes
Supplemental Figure 4 from Early Changes in Circulating Cell-Free KRAS G12C Predict Response to Adagrasib in KRAS Mutant Non–Small Cell Lung Cancer Patients
Cloud P. Paweletz, Grace A. Heavey, Yanan Kuang, Emily Durlacher et autres
0 citations
Supplementary Data 1 from Early Changes in Circulating Cell-Free KRAS G12C Predict Response to Adagrasib in KRAS Mutant Non–Small Cell Lung Cancer Patients
Cloud P. Paweletz, Grace A. Heavey, Yanan Kuang, Emily Durlacher et autres
0 citations
Supplemental Figure 3 from Early Changes in Circulating Cell-Free KRAS G12C Predict Response to Adagrasib in KRAS Mutant Non–Small Cell Lung Cancer Patients
Cloud P. Paweletz, Grace A. Heavey, Yanan Kuang, Emily Durlacher et autres
0 citations
Supplemental Figure 2 from Early Changes in Circulating Cell-Free KRAS G12C Predict Response to Adagrasib in KRAS Mutant Non–Small Cell Lung Cancer Patients
Cloud P. Paweletz, Grace A. Heavey, Yanan Kuang, Emily Durlacher et autres
0 citations
1317 AMPLIFY-7P Phase 2: T cell responses induced by ELI-002 7P, a lymph node-targeted amphiphile therapeutic cancer vaccine in patients with KRAS mutated pancreatic ductal adenocarcinoma
Lisa K. McNeil, James Perry, Julia P Snyder, Xavier Cabana Puig et autres
us (code pays fourni par la source)
1 citation
Lymph node-targeted, mKRAS-specific amphiphile vaccine in pancreatic and colorectal cancer: phase 1 AMPLIFY-201 trial final results
Zev A. Wainberg, Colin D. Weekes, Muhammad Furqan, Pashtoon Murtaza Kasi et autres
us (code pays fourni par la source)
70 citations
Nature Medicine
1473 AMPLIFY-7P phase 1a: lymph node-targeted amphiphile therapeutic cancer vaccine in patients with high relapse risk KRAS mutated pancreatic ductal adenocarcinoma and colorectal cancer
Lisa K. McNeil, James Perry, Amy Tavares, Julia P Snyder et autres
4 citations
Supplementary Data 1 from Early changes in circulating cell free KRAS G12C predicts response to adagrasib in KRAS mutant non-small cell lung cancer patients
Cloud P. Paweletz, Grace A. Heavey, Yanan Kuang, Emily Durlacher et autres
0 citations
Supplemental Figure 3 from Early changes in circulating cell free KRAS G12C predicts response to adagrasib in KRAS mutant non-small cell lung cancer patients
Cloud P. Paweletz, Grace A. Heavey, Yanan Kuang, Emily Durlacher et autres
0 citations
Supplemental Figure 1 from Early changes in circulating cell free KRAS G12C predicts response to adagrasib in KRAS mutant non-small cell lung cancer patients
Cloud P. Paweletz, Grace A. Heavey, Yanan Kuang, Emily Durlacher et autres
0 citations
Supplemental Figure 2 from Early changes in circulating cell free KRAS G12C predicts response to adagrasib in KRAS mutant non-small cell lung cancer patients
Cloud P. Paweletz, Grace A. Heavey, Yanan Kuang, Emily Durlacher et autres
0 citations
BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.